Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Parkinson's Disease (pd) Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

6 recruiting trials for Parkinson's Disease (pd). Eligibility criteria explained in plain English.

TrialFinderData lists 6 Parkinson's Disease (pd) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Research is led by Chang Gung Memorial Hospital (1), Ludwig-Maximilians - University of Munich (1), University of Minnesota (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Age (other, 1 trial), followed by Parkinson's disease (PD), No intervention (observational study).

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
6
Total Trials
6
Recruiting Now
0
Phase 3 Trials
6
Sponsors

Track Parkinson's Disease (pd) trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT07568951

Impact of Force Control of Hip Abductor Muscles in Healthy Adults and Individuals With Parkinson's Disease

Both aging and Parkinson's disease (PD) negatively affect postural control and increase the risk of falls, with frontal plane balance being particularly challenging for these...

Sponsor: Chang Gung Memorial HospitalEnrolling: 2102 locations
RECRUITINGNCT07336199

Pairing Subjective Patient Rating and DBS Programming

This multicenter, prospective and retrospective diagnostic study investigates personalized programming strategies for deep brain stimulation (DBS) in patients with Parkinson's...

Sponsor: Ludwig-Maximilians - University of MunichEnrolling: 251 location
RECRUITINGNCT07226284

Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease

This study is designed to better understand the mechanisms contributing to impaired activation of leg muscles in people with Parkinson's disease (PD) and to test if stimulation of...

Sponsor: University of MinnesotaEnrolling: 751 location
RECRUITINGNCT06874803

Acupuncture and Moxibustion for Motor Symptoms in Early Parkinson's Disease

This study evaluates the clinical effect and safety of acupuncture combined with moxibustion in improving motor symptoms of early-stage Parkinson's Disease (PD) patients, by...

Sponsor: Jiani WuEnrolling: 601 location
RECRUITINGNCT07606547

Biomechanical Effects of EMST® on Swallowing Function in Parkinson's Disease

The aim of this non-randomized intervention study is to investigate the detailed effects of a structured four-week EMST® training program on the biomechanics of swallowing...

Sponsor: University Hospital MuensterEnrolling: 301 location
RECRUITINGNCT07380204

Quantification of Hsp90 in the Human Brain

This study tests the radiolabeled molecule ("tracer"), \[¹¹C\]HSP990, using positron emission tomography (PET) imaging to assess whether it can be used to measure levels of Heat...

Sponsor: Universitaire Ziekenhuizen KU LeuvenEnrolling: 481 location

Frequently Asked Questions

There are currently 6 clinical trials for Parkinson's Disease (pd), with 6 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Parkinson's Disease (pd), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Parkinson's Disease (pd), representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.